Sunovion Submits New Drug Application for Dasotraline to the FDA for the Treatment of Patients with ADHD SUMITOMO DAINIPPON PHARMA Co., Ltd Sunovion Submits Friday September 1st, 2017By Tokio X'press FDA, JPN SUMITOMO DAINIPPON PHARMA
